Clinical trial
Can Additional Drug Therapy Accelerate Response Time to Antidepressants
NCT00221494 · Mark Frye, Other · Withdrawn
Key facts
| NCT number | NCT00221494 |
|---|---|
| Title | Can Additional Drug Therapy Accelerate Response Time to Antidepressants |
| Official title | Can Additional Drug Therapy Accelerate Response Time to Antidepressants: A Double-blind, Placebo-controlled Randomization Research Study for Major Depression |
| Lead sponsor | Mark Frye, Other |
| Collaborators | University of California, Los Angeles |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Drug |
| Interventions | citalopram + tiodothyronine, or + pindolol, or + placebo |
| Enrollment | 0 |
| Start date | Jan 1, 2004 |
| Primary completion | Jun 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Jun 1, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: